138 related articles for article (PubMed ID: 9387952)
1. Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease.
Jankelson D; Hosseini K; Mather LE; Seale JP; Young IH
Eur Respir J; 1997 Oct; 10(10):2270-4. PubMed ID: 9387952
[TBL] [Abstract][Full Text] [Related]
2. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.
Young IH; Daviskas E; Keena VA
Thorax; 1989 May; 44(5):387-90. PubMed ID: 2669222
[TBL] [Abstract][Full Text] [Related]
3. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient.
Beauford W; Saylor TT; Stansbury DW; Avalos K; Light RW
Chest; 1993 Jul; 104(1):175-8. PubMed ID: 8325064
[TBL] [Abstract][Full Text] [Related]
4. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
[TBL] [Abstract][Full Text] [Related]
5. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
[TBL] [Abstract][Full Text] [Related]
6. Nebulized morphine: one intervention for end-stage chronic obstructive pulmonary disease (COPD).
Lord E
AARN News Lett; 1997 Nov; 53(10):10-1. PubMed ID: 9444084
[No Abstract] [Full Text] [Related]
7. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.
Leung R; Hill P; Burdon J
Thorax; 1996 Jun; 51(6):596-600. PubMed ID: 8693440
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease.
Masood AR; Reed JW; Thomas SH
Thorax; 1995 Jun; 50(6):629-34. PubMed ID: 7638804
[TBL] [Abstract][Full Text] [Related]
9. Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.
Janowiak P; Krajnik M; Podolec Z; Bandurski T; Damps-Konstańska I; Sobański P; Currow DC; Jassem E
BMC Pulm Med; 2017 Dec; 17(1):186. PubMed ID: 29228935
[TBL] [Abstract][Full Text] [Related]
10. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis.
Cohen SP; Dawson TC
Pediatrics; 2002 Sep; 110(3):e38. PubMed ID: 12205288
[TBL] [Abstract][Full Text] [Related]
11. Low-dose nebulized morphine does not improve exercise in interstitial lung disease.
Harris-Eze AO; Sridhar G; Clemens RE; Zintel TA; Gallagher CG; Marciniuk DD
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1940-5. PubMed ID: 8520759
[TBL] [Abstract][Full Text] [Related]
12. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
13. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
[TBL] [Abstract][Full Text] [Related]
14. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
Chiang LL; Yu CT; Kuo HP
Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
[TBL] [Abstract][Full Text] [Related]
15. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man.
Masood AR; Subhan MM; Reed JW; Thomas SH
Clin Sci (Lond); 1995 Apr; 88(4):447-52. PubMed ID: 7789047
[TBL] [Abstract][Full Text] [Related]
17. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
[TBL] [Abstract][Full Text] [Related]
18. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
19. Nebulized morphine for relief of dyspnea due to chronic lung disease.
Brown SJ; Eichner SF; Jones JR
Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
[TBL] [Abstract][Full Text] [Related]
20. Nebulised morphine for severe interstitial lung disease.
Polosa R; Simidchiev A; Walters EH
Cochrane Database Syst Rev; 2002; 2002(3):CD002872. PubMed ID: 12137662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
